Based on the measurements of operating efficiency obtained from LifeMD's historical financial statements, LifeMD Inc is doing better financially today then in previous quarter. It has a moderate probability of reporting better financial numbers in April. At present, LifeMD's Short and Long Term Debt Total is projected to increase significantly based on the last few years of reporting. The current year's Other Current Liabilities is expected to grow to about 38.7 T, whereas Net Debt is projected to grow to (18.8 T). Key indicators impacting LifeMD's financial strength include:
The financial analysis of LifeMD is a critical element in measuring its lifeblood. Investors should not minimize LifeMD's ability to pay suppliers or employees on time, ensuring interest payments are not accumulating.
Please note, the presentation of LifeMD's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, LifeMD's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of LifeMD's management manipulating its earnings.
LifeMD Stock Summary
LifeMD competes with Streamline Health, HealthStream, National Research, Privia Health, and Evolent Health. LifeMD, Inc. operates as a direct-to-patient telehealth company that connects consumers to healthcare professionals for care across various indications, including concierge care, mens sexual health, dermatology, and others in the United States. LifeMD, Inc. was founded in 1994 and is headquartered in New York, New York. LifeMD operates under Pharmaceutical Retailers classification in the United States and is traded on NASDAQ Exchange. It employs 196 people.
Comparative valuation techniques use various fundamental indicators to help in determining LifeMD's current stock value. Our valuation model uses many indicators to compare LifeMD value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across LifeMD competition to find correlations between indicators driving LifeMD's intrinsic value. More Info.
LifeMD Inc is rated below average in return on equity category among its peers. It also is rated below average in return on asset category among its peers . At present, LifeMD's Return On Equity is projected to drop slightly based on the last few years of reporting. Comparative valuation analysis is a catch-all technique that is used if you cannot value LifeMD by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.
LifeMD Inc Systematic Risk
LifeMD's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. LifeMD volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was thirty with a total number of output elements of thirty-one. The Beta measures systematic risk based on how returns on LifeMD Inc correlated with the market. If Beta is less than 0 LifeMD generally moves in the opposite direction as compared to the market. If LifeMD Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one LifeMD Inc is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of LifeMD is generally in the same direction as the market. If Beta > 1 LifeMD moves generally in the same direction as, but more than the movement of the benchmark.
Today, most investors in LifeMD Stock are looking for potential investment opportunities by analyzing not only static indicators but also various LifeMD's growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of LifeMD growth as a starting point in their analysis.
Price Earnings To Growth Ratio
0.47
At present, LifeMD's Price Earnings To Growth Ratio is projected to increase slightly based on the last few years of reporting.
LifeMD March 19, 2025 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of LifeMD help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of LifeMD Inc. We use our internally-developed statistical techniques to arrive at the intrinsic value of LifeMD Inc based on widely used predictive technical indicators. In general, we focus on analyzing LifeMD Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build LifeMD's daily price indicators and compare them against related drivers.
When running LifeMD's price analysis, check to measure LifeMD's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy LifeMD is operating at the current time. Most of LifeMD's value examination focuses on studying past and present price action to predict the probability of LifeMD's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move LifeMD's price. Additionally, you may evaluate how the addition of LifeMD to your portfolios can decrease your overall portfolio volatility.